Funding for this research was provided by:
Received: 27 June 2018
Accepted: 25 September 2018
First Online: 5 October 2018
Ethics approval and consent to participate
: With regards to potential competing interests, Dr. Imberti reports receiving consulting fees from GB Pharma s.r.l.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.